IRVING, Texas, March 29, 2010 (GLOBE NEWSWIRE) -- Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies, announced today that one of the foremost dermatopathologists in the United States has joined an already unsurpassed team of subspecialists at its subsidiary Caris Diagnostics. Caris continues to develop a broad, prolific team of pathologists, which currently includes more than 60 experts across the subspecialties of dermatopathology, gastrointestinal pathology, hematopathology, urologic pathology, and oncologic pathology.
Evan R. Farmer, M.D. has more than three decades of experience in dermatopathology. He completed his residency in dermatology at Johns Hopkins University and his fellowship in dermatopathology at the Armed Forces Institute of Pathology. For four decades, Dr. Farmer has served as Professor of Dermatology and Pathology at Johns Hopkins University, Virginia Commonwealth University School of Medicine, Eastern Virginia Medical School, and Indiana University School of Medicine. He has also served as Department Chair at Indiana University and Dean of Eastern Virginia Medical School. His distinguished career also includes terms as President of the American Dermatological Association, Vice President of the American Academy of Dermatology, and member of the Board of Directors of the American Board of Dermatology.
"We are honored that Dr. Farmer has joined our team," said Richard H. Lash, M.D., Chief Medical Officer of Caris. "Dr. Farmer brings a wealth of experience to our faculty and will help expand Caris Diagnostics' position as the premier diagnostics services provider for dermatopathology. He will help direct the various ongoing educational activities that are integral to our practice. Acquiring the services of distinguished pathologists such as Dr. Farmer demonstrates our commitment to diagnostic excellence and to broadening the expertise and credentials of our already unprecedented team of pathologists."
About Caris Life Sciences
Caris Life Sciences, a leading biosciences company, specializes in the development and commercialization of the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies, in the fields of oncology, dermatopathology, hematopathology, gastrointestinal and urologic pathology. The company provides academic-caliber medical consults through its industry-leading team of expert, subspecialty pathologists. Caris Life Sciences also offers advanced molecular analyses of patient samples through prognostic testing services and genomic, transcriptomic, and proteomic profiling to assist physicians in their treatment of cancer and other complex diseases. Biopsies from thousands of patients are received daily from physicians throughout the U.S., for analysis by Caris. Founded in 1996, the company is headquartered in Irving, Texas, and operates laboratories at the headquarters, as well as in Phoenix, Arizona and Newton, Massachusetts. Additional information is available at www.carislifesciences.com.